You have 9 free searches left this month | for more free features.

TCR transduced T cells

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Epithelial Tumors Trial in Portland (TCR-transduced T cells, CDX-1140, Pembrolizumab)

Not yet recruiting
  • Malignant Epithelial Neoplasms
  • TCR-transduced T cells
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Apr 22, 2022

Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

Recruiting
  • Kidney Cancer
  • cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 2, 2022

Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Aldesleukin
  • +12 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 9, 2023

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Advanced Solid Tumor Trial in Beijing (YK0901 cells)

Not yet recruiting
  • Advanced Solid Tumor
  • YK0901 cells
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital
Jun 27, 2023

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Tumor Trial in

Suspended
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 23, 2022

Advanced Solid Tumors Trial in Belgium, Germany, Spain (Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR)

Recruiting
  • Advanced Solid Tumors
  • Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
  • Ghent, Belgium
  • +2 more
Jun 23, 2022

Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))

Recruiting
  • Pancreatic Cancer
  • TCR-T Cells Injection(GB3010 Cells Injection)
  • ShangHai, Shanghai, China
    Ruijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Sep 19, 2023

HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

Not yet recruiting
  • HPV-Associated Cervical Carcinoma
  • +16 more
  • Conditioning, E7 TCR-T cells, and aldesleukin
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 17, 2023

EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV Infection After Allogenic HSCT
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 3, 2023

EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV-associated Hemophagocytic Lymphohistiocytosis
  • EBV Infection
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 12, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Autologous Mesothelin-specific TCR-T Cells
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 31, 2023

Chronic Hepatitis B Trial in Beijing (TCR-T)

Active, not recruiting
  • Chronic Hepatitis B
  • TCR-T
  • Beijing, China
    The Fifth Medical Center of PLA General Hospital
Jun 13, 2023

Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

Active, not recruiting
  • Malignant Neoplasm
  • aldesleukin
  • +7 more
  • Los Angeles, California
    University of California at Los Angeles (UCLA )
Dec 1, 2022

Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • PK Blood Collection
  • +2 more
  • (no location specified)
Nov 1, 2022

Advanced Solid Tumor Trial in Dallas (TCRT-ESO-A2)

Withdrawn
  • Advanced Solid Tumor
  • TCRT-ESO-A2
  • (no location specified)
Aug 31, 2022

Trial (Individual Patient TCR-Transduced PBL)

No longer available
    • Individual Patient TCR-Transduced PBL
    • (no location specified)
    Sep 3, 2020

    Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 12, 2023

    Solid Tumors Trial (TCR-T cells, Fludarabine, Cyclophosphamide Capsules)

    Not yet recruiting
    • Solid Tumors
    • TCR-T cells
    • +4 more
    • (no location specified)
    Dec 12, 2022

    Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)

    Recruiting
    • Cervical Carcinoma
    • TC-E202 cells
    • +3 more
    • Chongqing, Chongqing, China
      Xiaochun Cheng
    Oct 20, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Active, not recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +11 more
    • Aldesleukin
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 13, 2022

    TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSH01 injection)

    Recruiting
    • TCR-T Cells
    • +2 more
    • KSH01 injection
    • Nanning, Guang XI, China
      The first affiliated hospital of Guang Xi medical university
    Sep 14, 2022

    Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

    Not yet recruiting
    • Synovial Sarcoma
    • Fludarabine phosphate
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023